Biologicals

Technical report series: cells and tissues

Requirements for the use of animal cells as in vitro substrates for the production of biologicals (Addendum 2003)

WHO Technical Report Series, No. 927, 2005

Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. Proposed replacement of TRS 878, Annex 1

Title 2: Requirements for the use of animal cells as in vitro substrates for the production of biologicals-Addendum 2003)

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



NEW PUBLICATIONS

TRS 1004 - WHO Expert Committee on Biological Standardization, Sixty-seventh report

UPCOMING EVENTS


  • WHO Working Group meeting on Respiratory Syncytial Virus (RSV) Vaccine Standardization, WHO headquarters, Geneva, Switzerland, 13-15 September 2017
  • WHO Second Working Group Meeting on Developing WHO Guidelines on safe production of polio vaccines, WHO HQ Salle D, 19-20 September 2017
  • WHO Workshop on Implementation of Good Manufacturing Practices for Biological Products, Bangkok, Thailand 15-17 November 2017
  • WHO Implementation Workshop on the Quality, Safety and Efficacy of Typhoid Conjugate Vaccines, Osong, Chungju-si, The Republic of Korea, 21-13 November 2017

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971